Hôpital La Timone - APHM — Clinical Trial Site

15 Registered trials

9 Currently recruiting

Organisation

Hôpital La Timone - APHM

Location

Marseille, France

Identifier

ORL-000002521

Address

264 Rue Saint-Pierre, 13005, France

Departments

Centre d'Essais Précoces en Cancérologie de Marseille (CEPCM)
Centre de Référence des Maladies Neuromusculaires et de la SLA
Chirurgie digestive et générale
Department of Internal Medicine
Hematology-oncology department
Médecine vasculaire
Medical oncology
Neuro - Oncology
Oncologie multidisciplinaire et innovations thérapeutiques
Oncology
Oncology for pediatrics
Service d'Oncologie Digestive
Service Oncologie Pédiatrique

Clinical trials at this site (15)

Search interface

Upfront trastuzumab-deruxtecan plus capecitabine and bevacizumab for patients with HER2 positive metastatic colorectal cancer: the CHIMERA t… Recruiting

2024-519479-24-00 metastatic colorectal cancer 4 2025-11-21
Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Plac… Recruiting

2023-507801-32-00 Isolated Subsegmental Pulmonary Embolism 6 2026-04-22
TARLATEM : Combination of TARLAtamab and TEMozolomide in patients with central nervous system tumors. A multicenter, open-label Phase I/II t… Recruiting

2023-510568-11-00 High grade brain tumors 9 2025-11-18
PRODIGE 90 - FFCD 22024 - PREDIR-NEOREC - Neoadjuvant dostarlimab with short course radiotherapy in a watch-and-wait strategy for microsatel… Recruiting

2024-510772-20-00 Rectal cancer locally advanced with microsatellite unst 4 2025-02-06
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
PRODIGE 98- AMPIRINOX : Randomized, multicenter, Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or ge… Recruiting

2024-511070-68-01 Ampullary adenocarcinoma 5 2024-09-24
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
Hyperthermic Intraperitoneal Chemotherapy in the treatment of Ovarian Cancer relapse Recruiting

2024-517390-24-00 Ovarian epithelial cancer : intraperitoneal resectable 5 2011-04-26
ALS phase II study of NX210c (SEALS) Ended

2023-508895-13-00 Amyotrophic Lateral Sclerosis (ALS) 4 2024-10-25
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Ended

2024-517489-41-00 High-risk stage III colon cancer 5 2017-03-27
KONFIDENT-KID Ended

2023-507591-44-00 Hereditary Angioedema Type I or II 5 2024-10-24
A phase I of TG6050 in the treatment of patients with metastatic lung cancer Ended

2024-513093-22-00 Non-small cell lung cancer (NSCLC) 1 2023-03-27
PHASE 1/2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE OR IN COMBINATION WITH TOPOTECAN AND CYCL… Ended

2024-511975-14-00 recurrent/refractory Ewing sarcoma 9 2022-05-26
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer Ended

2023-506922-35-00 Locally Advanced or Metastatic Solid Tumors with EGFR a 1 2022-01-24
Trial assessing the efficacy of suraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer Ended

2024-516558-24-00 Pancreatic (PAAD) 4